S. Joosten-Achjanie

Vascular targeting effect of combretastatin A‐4 phosphate dominates the inherent angiogenesis inhibitory activity

P. Lambin, W. Landuyt, A. Griffioen, 2003, International journal of cancer.

Microvessel density in unknown primary tumors

J. Arends, H. Hillen, S. Joosten-Achjanie, 1997, International journal of cancer.

Relevance of the expression of bcl-2 in combination with p53 as a prognostic factor in breast cancer.

J. Arends, P. Hupperets, H. Hillen, 1998, Anticancer research.

MIB-1 labelling index is an independent prognostic marker in primary breast cancer.

J. Arends, P. Hupperets, H. Hillen, 1998, British Journal of Cancer.

CD 44 v 6 is not a prognostic factor in primary breast cancer

J. Arends, P. Hupperets, H. Hillen, 2005 .

CD44v6 is not a prognostic factor in primary breast cancer.

J. Arends, P. Hupperets, H. Hillen, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

pS2 is an independent prognostic factor for post-relapse survival in primary breast cancer.

J. Arends, P. Hupperets, H. Hillen, 1998, Anticancer research.

Anti-apoptotic phenotype is associated with decreased locoregional recurrence rate in breast cancer.

J. Jager, J. Arends, L. Schouten, 1998, Anticancer research.